- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00382551
The Effect of Beer, Red Wine and Fruit Juice on Blood Vessel Function in Persons With Cardiovascular Disease
January 29, 2009 updated by: Aalborg University Hospital
The Effect of Alcohol and Polyphenolic Compounds on Endothelial Function
To study the effect of red wine, beer and fruit juice on endothelial function in patients with coronary Heart disease.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aalborg, Denmark, 9000
- Department of Cardiology, Aalborg Hospital, Science and Innovation Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men or postmenopausal women with stable coronary heart disease
- Coronary heart disease should be verified by coronary angiography with at least 50% stenosis in at least one coronary vessel.
Exclusion Criteria:
- Patients with myocardial infarction within the last tree months
- Persons with a present or earlier alcohol abuse
- Persons with a present or earlier drug abuse
- Person with malign disease
- Persons, that we consider unsuitable to carry through the examines.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Changes in flow-mediated vasodilation after 2 weeks intervention compared with baseline
|
Secondary Outcome Measures
Outcome Measure |
---|
Lipid status after 2 weeks intervention compared with baseline
|
Effects in Coagulation factors after 2 weeks intervention
|
Effects on markers of inflammation after 2 weeks intervention
|
Effects on markers of endothelial function after 2 weeks intervention
|
Changes in the overall antioxidant activity in plasma after 2 weeks intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Erik B Schmidt, Professor, Department of Cardiology, Aalborg Hospital , Aarhus University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Study Registration Dates
First Submitted
September 28, 2006
First Submitted That Met QC Criteria
September 28, 2006
First Posted (Estimate)
September 29, 2006
Study Record Updates
Last Update Posted (Estimate)
January 30, 2009
Last Update Submitted That Met QC Criteria
January 29, 2009
Last Verified
January 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VN-20060043
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Heart Disease
-
Peking University Third HospitalCompletedCoronary Microvascular Dysfunction | Obstructive Coronary Heart DiseaseChina
-
Centro de estudios en Cardiologia IntervencionistaCompletedCoronary Heart Disease | Coronary RestenosisArgentina
-
Shenyang Northern HospitalNot yet recruitingCoronary Heart Disease (CHD)China
-
Johns Hopkins UniversityCanon Medical Systems, USARecruiting
-
MedImmune LLCCompletedStable Coronary Heart DiseaseUnited States
-
Medical University of LodzBaxter Healthcare CorporationUnknownCHD - Coronary Heart DiseasePoland
-
University of ZurichCompletedStable Coronary Heart DiseaseSwitzerland
-
Hamad Medical CorporationMayo ClinicCompleted
-
Deutsches Herzzentrum MuenchenCompletedCoronary Heart DiseaseGermany
-
Henan Institute of Cardiovascular EpidemiologyNot yet recruitingStable Coronary Heart Disease
Clinical Trials on Moderate daily consumption of Red wine
-
University of TurkuTampere UniversityCompleted
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo; IBRAVINCompletedRed Wine Effects Upon Gut Flora and Plasma Levels of Trimethylamine-N-oxide (TMAO) - WineFlora StudyAtherosclerosis | Gut Microbiota | Trimethylamine-N-oxide | Effects of Red Wine
-
University of MilanCompleted
-
Purdue UniversityUnited States Agency for International Development (USAID)Completed
-
European Research Advisory BoardCompleted
-
Texas A&M UniversityUnknownCognitive Change | Nutritional Anemia | Diet, Healthy | Nutrient Deficiency | Diet; Deficiency | Visual Spatial Processing | Dietary Deficiency | Dietary B12 Deficiency | Dietary Zinc Deficiency | Dietary Vitamin B12 Deficiency Anemia | Dietary Deficiency of Selenium and Vitamin EUnited States
-
Parc de Salut MarCompleted
-
South Dakota State UniversityCompletedObesity | Sarcopenia | AgingUnited States
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityCompletedEndothelial Progenitor Cells Numbers | Endothelial Function (FMD)Taiwan
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS)Completed